passiv
immun
enter
viral
infect
depend
upon
continu
presenc
gut
lumen
protect
level
specif
antibodi
articl
examin
method
current
use
enhanc
titr
durat
specif
antibodi
mammari
secret
cow
pig
particular
refer
rotaviru
coronaviru
infect
addit
potenti
problem
found
attempt
produc
vaccin
viral
infect
outlin
neonat
diarrhoea
complex
diseas
associ
number
infecti
agent
occur
either
singli
combin
domest
anim
econom
loss
suffer
result
mortal
rang
also
veterinari
cost
decreas
product
survivor
viral
agent
commonli
associ
syndrom
rotaviru
coronaviru
found
primari
pathogen
calv
piglet
virus
frequent
isol
period
birth
wean
anim
age
intens
studi
frequenc
sever
infect
anim
age
howev
suscept
subclin
infect
appar
common
adult
cow
pig
neonat
calv
incid
rotaviru
coronaviru
associ
diarrhoea
similar
vari
situat
neonat
piglet
less
clear
rotaviru
infect
appar
common
whilst
transmiss
gastroenter
viru
tgev
prototyp
enter
coronaviru
swine
exampl
season
coldweath
diseas
probabl
relat
thermal
sensit
viru
effect
coldstress
convert
subclin
clinic
infect
pathogenesi
enter
rotaviru
coronaviru
diseas
swine
cattl
similar
contrast
tgev
howev
rotavirus
appear
confin
alimentari
tract
predominantli
small
intestin
although
evid
lamb
piglet
infect
larg
intestin
infect
character
diarrhoea
dehydr
caus
function
anatom
loss
absorbt
cell
intestin
princip
site
viru
replic
shown
intestin
villu
epithelium
infect
cell
lost
tip
villi
replac
immatur
crypt
cell
gener
dimunit
number
size
villi
progress
replac
epithelium
squamou
cuboid
cell
lack
brush
bordep
immatur
cell
shown
possess
reduc
level
disaccharidas
loss
absorpt
cell
intestin
assum
result
observ
malabsorpt
syndrom
exacerb
decreas
abil
util
dietari
lactos
result
accumul
larg
intestin
therebi
prevent
absorpt
water
exert
osmot
effect
result
sever
enter
viral
infect
first
week
life
passiv
acquir
antibodi
major
sourc
protect
calv
pig
select
transfer
immunogiobulin
matern
foetal
circul
last
third
pregnanc
instead
period
immedi
follow
birth
matern
immunoglobulin
acquir
colostrum
ofth
dam
absorpt
colostr
immunoglobulin
intestin
epitheli
cell
nonselect
process
last
h
factor
present
colostrum
may
influenc
absorpt
immunoglobulin
help
prevent
proteolyt
degred
addit
immunogiobulin
colostrum
milk
recent
shown
contain
function
immunocompet
cell
includ
macrophag
b
lymphocyt
contrast
colostr
absorpt
highli
specif
mechan
oper
colostrumform
r
gland
cattl
pig
caus
larg
amount
igg
rel
iga
igm
concentr
coiostrum
q
lgg
passiv
acquir
neonat
colostrum
persist
serum
sever
week
protect
system
infect
tgev
infect
pig
rotaviru
infect
calv
g
circul
antibodi
found
littl
valu
resist
infect
appear
mediat
instead
local
immun
epitheli
surfac
intestin
cattl
select
transfer
igg
serum
milk
continu
throughout
lactat
although
reduc
level
compar
colostrum
format
concentr
three
class
ofimmunoglobulin
significantli
reduc
milk
consequ
igg
remain
primari
immunoglobulin
bovin
contrasl
pig
concentr
lgg
decreas
first
week
lactat
whilst
secretori
lga
declin
threefold
leav
becom
predomin
class
immunoglobulin
swine
milld
adult
cattl
seroposit
rotaviru
coronaviru
antibodi
dramat
declin
colostr
antibodi
titr
transit
milld
reflect
reduct
concentr
immunoglobulin
partial
explain
high
incid
rotaviru
coronaviru
infect
calv
older
five
day
titr
passiv
deriv
protect
antibodi
declin
despit
presenc
one
common
antigen
demonstr
rotavirus
isol
differ
speci
differ
antigen
recent
shown
differ
serotyp
exist
within
isol
obtain
singl
speci
exist
least
two
differ
serotyp
porcin
rotaviru
least
three
distinct
bovin
serotyp
describ
bridger
et
al
suggest
occurr
ofintermedi
bovin
rotaviru
type
although
work
essenti
clarifi
situat
recent
isol
possess
distinct
morpholog
rotavirus
found
lack
common
group
antigen
date
atyp
rotavirus
isol
human
bird
calv
lamb
pig
pig
preliminari
result
use
two
previous
character
atyp
isol
indic
distinct
share
common
group
antigen
observ
extend
snodgrass
et
al
ga
suggest
occurr
least
four
distinct
group
ofrotavirus
base
group
antigen
signific
serotyp
differ
observ
rotavirus
vitro
still
need
fulli
assess
vivo
orbivirus
also
member
reovirida
possess
mani
serotyp
requir
use
multival
vaccin
mani
crossprotect
studi
carri
use
differ
rotaviru
serotyp
contradictori
data
inconclus
exampl
utero
vaccin
calv
bovin
rotaviru
found
protect
diarrhoea
caus
challeng
human
rotaviru
serotyp
although
challeng
viru
still
shed
contrast
one
three
calv
protect
bovin
rotaviru
challeng
vaccin
human
serotyp
equin
rotaviru
tm
anim
shed
detect
viru
furthermor
piglet
vaccin
human
rotaviru
challeng
porcin
rotaviru
protect
clinic
diseas
enhanc
lactogen
immun
c
f
crouch
shed
viru
use
defin
challeng
system
evid
obtain
indic
rotaviru
isol
differ
anim
speci
differ
serotyp
show
poor
crossprotect
properti
vivo
tm
observ
confirm
extend
studi
gnotobiot
calv
piglet
show
crossprotect
occur
rotavirus
serotyp
even
minor
serotyp
differ
could
suffici
affect
crossprotect
g
evid
lack
crossprotect
rotaviru
serotyp
obtain
studi
sequenti
infect
subsequ
rotaviru
infect
found
associ
differ
serotyp
situat
coronavirus
simpler
date
coronavirus
isol
mammal
bird
group
four
antigen
class
littl
crossreact
demonstr
class
tm
tgev
antigen
distinct
bovin
enter
coronaviru
tm
well
anoth
yet
unclassifi
coronaviru
caus
diarrhoea
pig
two
approach
use
attempt
provid
calv
protect
rotaviru
coronaviru
infect
first
approach
involv
oral
vaccin
live
attenu
viru
order
stimul
activ
immun
calf
scourvax
ii
norden
laboratori
incid
diarrhoea
neonat
calv
oral
vaccin
attenu
rotaviru
found
reduc
vaccin
proven
effect
blind
field
trial
number
limit
associ
approach
includ
potenti
vaccin
regain
virul
high
incid
seroposit
adult
anim
lead
possibl
interfer
vaccin
viru
replic
matern
deriv
milk
antibodi
rel
immatur
neonat
immun
system
second
approach
util
passiv
protect
produc
lactogen
immun
stimul
matern
vaccin
attempt
vaccin
dam
use
attenu
live
vaccin
calf
guard
norden
laboratori
fail
significantli
enhanc
milk
antibodi
titr
tabl
whilst
activ
adjuv
rotaviru
prepar
found
enhanc
level
specif
antibodi
coiostrum
milk
tabl
number
paramet
need
consid
attempt
optim
enhanc
antibodi
product
mammari
secret
dose
form
vaccin
consid
inactiv
vaccin
expect
rel
larg
amount
necessari
achiev
satisfactori
respons
process
inactiv
may
decreas
immunogen
viral
polypeptid
tabl
show
signific
differ
milk
antibodi
titr
obtain
follow
vaccin
cow
rotaviru
prepar
contain
either
elisa
unit
inactiv
emulsifi
freund
incomplet
adjuv
contrast
prepar
use
adjuv
aluminium
phosphat
higher
dose
result
greater
antibodi
respons
similar
result
use
oil
adjuv
rotaviru
vaccin
previous
report
ss
formaldehyd
inactiv
rotaviru
vaccin
use
success
enhanc
milk
antibodi
titr
compar
control
worker
report
increas
antibodi
respons
usingpropriolacton
inactiv
agentol
although
saif
et
al
found
antibodi
titr
mammari
secret
least
tenfold
greater
cow
vaccin
binari
ethylenimin
inactiv
rotaviru
compar
vaccin
inactiv
rotaviru
adjuv
snodgrass
et
found
oilbas
adjuv
effect
alhydrogel
enhanc
rotaviru
antibodi
titr
mammari
secret
concur
data
present
worker
demonstr
satisfactori
immun
respons
follow
vaccin
use
oilbas
adjuv
gener
freund
incomplet
adjuv
rout
time
vaccin
extent
rout
time
vaccin
depend
upon
type
ofcattl
farm
thu
intramammari
rout
use
success
saifet
whilst
applic
dairi
cattl
may
practic
beef
cow
similarli
administr
viewpoint
singl
vaccin
would
prefer
regim
util
sever
dose
major
studi
report
signific
increas
rotaviru
antibodi
titr
mammari
secret
use
either
subcutan
intramuscular
inject
oiladjuv
vaccin
vaccin
also
prove
effect
administ
either
singl
doubl
dose
inject
prior
parturit
tabl
efficaci
immun
milk
mechan
provid
passiv
immun
rotaviru
challeng
examin
number
worker
alactogen
antibodi
origin
either
vaccin
vacc
control
cont
normal
cow
normal
bcalv
either
suckl
natur
suckl
fed
supplement
diet
contain
antibodi
supp
ccalv
either
challeng
experiment
exp
natur
expos
field
condit
field
day
challeng
eday
birth
r
day
start
experi
cow
vaccin
commerci
vaccin
nr
report
result
howev
difficult
compar
due
variat
feed
regim
use
immun
milk
also
challeng
system
use
amount
time
feed
oflactogen
antibodi
dose
virul
serotyp
viru
challeng
strain
use
affect
appar
suscept
calf
infect
situat
field
challeng
use
failur
protect
may
due
infect
rotaviru
serotyp
use
vaccin
possibl
agent
capabl
caus
diarrhoea
gener
investig
report
either
reduc
incid
rotaviru
shed
diarrhoea
one
studi
feed
oflactogen
antibodi
fail
significantli
affect
incid
onset
diarrhoea
major
anim
receiv
passiv
immun
appear
capabl
develop
activ
immun
period
consequ
vaccin
lead
elimin
clinic
diseas
rather
delay
onset
investig
immunoglobulin
isotyp
associ
protect
antibodi
induc
vaccin
bovin
milk
colostrum
suggest
igg
play
major
role
observ
agreement
discuss
earlier
concern
passiv
immun
bovin
contrast
bovin
system
evid
suggest
milk
colostr
immunoglobulin
iga
isotyp
effect
igg
isotyp
protect
piglet
infect
tgev
high
persist
level
lgg
may
howev
provid
degre
vaccin
vol
e
p
e
b
e
r
enhanc
lactogen
immun
c
e
crouch
protect
viru
challeng
result
observ
studi
examin
method
optimis
stimul
secretori
iga
antibodi
milk
origin
tgevspecif
iga
found
mammari
secret
remain
somewhat
obscur
although
good
correl
presenc
infect
intestin
tract
secretori
iga
porcin
milk
almost
certainli
local
produc
mammari
glan
order
explain
phenomenon
suggest
specificallysensit
igasecret
lymphocyt
may
migrat
mammari
gland
follow
initi
sensit
intestin
interrelationship
intestin
mammari
immun
system
also
propos
rabbit
human
direct
evid
migrat
influenc
pregnancyassoci
hormon
obtain
micd
summari
variou
investig
antibodi
respons
efficaci
lactogen
immun
follow
differ
vaccin
protocol
given
tabl
reduc
immunogen
pig
cell
cultur
attenu
tgev
describ
oral
vaccin
live
attenu
tge
vaccin
whilst
produc
neutral
antibodi
stimul
good
lactogen
immun
suckl
pig
intramuscular
vaccin
sow
live
attenu
tgev
lead
enhanc
specif
igg
level
colostrum
milld
l
higher
titr
oftgevspecif
igg
achiev
use
intramammari
inject
associ
increas
protect
provid
suckl
pig
result
support
observ
worker
felin
infecti
periton
viru
fipv
member
antigen
class
tgev
consequ
two
virus
serolog
relat
good
level
crossprotect
associ
high
titr
tgevspecif
neutral
antibodi
report
sow
vaccin
oral
fipw
contrast
result
recent
studi
shown
whilst
tgev
neutral
antibodi
lgg
subclass
stimul
milk
colostrum
surviv
rate
suckl
pig
low
may
possibl
boost
level
oflga
mammari
secret
preliminari
investig
reveal
specif
secretori
lga
level
milk
enhanc
parenter
inject
parturit
tgev
rotaviru
natur
infect
oral
prime
anim
similar
approach
also
combin
oral
parenter
antigen
administr
propos
mean
provid
lactogen
immun
colibacillosi
pig
lgg
induc
readili
mammari
secret
cattl
intramuscular
subcutan
inject
adjuv
immunogen
pig
howev
whilst
live
virul
viru
capabl
induc
high
level
iga
iri
milk
appar
ideal
candid
vaccin
viru
must
suffici
attenu
produc
mild
diseas
neonat
pig
whilst
retain
suffici
virul
infect
intestin
tract
adult
swine
work
essenti
possibl
use
inactiv
vaccin
boost
exist
iga
level
mammari
secret
may
requir
prior
natur
infect
sow
incid
vari
herd
associ
affect
upon
efficaci
vaccin
investig
varieti
strain
serotyp
rotavirus
obviou
import
respons
vaccin
cattl
swine
rotavirus
coronavirus
current
data
suggest
crossprotect
rotaviru
serotyp
limit
although
littl
inform
concern
specif
antibodi
induc
vaccin
previous
infect
anim
anim
natur
expos
varieti
serotyp
may
produc
heterogen
antibodi
respons
capabl
react
broad
spectrum
rotaviru
serotyp
appar
enhanc
lactogen
immun
vaccin
dam
provid
suitabl
mechan
neonat
pig
calv
protect
rotaviru
coronaviru
infect
product
truli
effect
vaccin
howev
await
work
area
outlin
